Pregled bibliografske jedinice broj: 1229713
Progress towards the 90-90-90 HIV targets in 11 EU countries
Progress towards the 90-90-90 HIV targets in 11 EU countries // 27th Conference on Retroviruses and Opportunistic Infections
Boston, USA, 2020. 1079, 1 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 1229713 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Progress towards the 90-90-90 HIV targets in 11 EU
countries
Autori
Vourli, Georgia ; Noori, Teymur ; Porter, Kholoud ; Begovac, Josip ; Delpech, Valerie ; Girardi, Enrico ; Gunsenheimer-Bartmeyer, Barbara ; Hernando, Victoria ; Obel, Niels ; Van Sighem, Ard ; Sönnerborg, Anders ; Supervie, Virginie ; Zangerle, Robert ; Touloumi, Giota
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Skup
27th Conference on Retroviruses and Opportunistic Infections
Mjesto i datum
Boston, USA, 08.-11.03.2020
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Antiretroviral treatment (ART) ; HIV ; care ; EU
Sažetak
Despite the availability of highly effective antiretroviral treatment (ART), delayed diagnosis and ART initiation, and poor retention in care remain barriers to reducing HIV incidence. We aimed to estimate progress towards the UNAIDS 90- 90-90 targets by constructing the continuum of HIV care (CoC) in 2016 in 11 European Union (EU) countries, overall and by key population and sex. Using surveillance and cohort data from Austria, Croatia, Denmark, Germany, Greece, France, Italy, the Netherlands, Spain, Sweden and the United Kingdom, a CoC was constructed with four stages: i) number of people living with HIV (PLHIV) ; ii) proportion of PLHIV ever diagnosed ; iii) proportion of diagnosed who initiated ART ; iv) proportion of treated who achieved viral suppression (≤200 copies/mL) at their last visit (July 2015- December 2016). The 11 countries represent 73% of EU population and 85% of PLHIV in the region. The estimated number of PLHIV in the participating countries at the end of 2016 was 702, 848, corresponding to 0.19% adult prevalence. Overall, we estimated that 87% of PLHIV were diagnosed ; 92% of those diagnosed had initiated ART ; and 91% of those on ART were virally suppressed. Therefore, among all PLHIV 73% were virally suppressed. The corresponding figures for men having sex with men (MSM) were: 86%, 93%, 93% (and among all PLHIV 74%) ; for people who inject drugs (PWID): 91%, 88%, 84% (67%) ; for heterosexuals: 86%, 92%, 91% (72%) ; for men: 87%, 92%, 91% (73%) and for women: 89%, 92%, 89% (73%). Substantial variation across countries was observed. The EU is near to reaching the 90-90-90 UNAIDS targets, and achieved the UNAIDS final target of 73% of all PLHIV with viral suppression. This finding represents a significant progress compared to 2013, where 60% of all PLHIV were virally suppressed. However, differences between countries and key populations persisted in 2016. To improve outcomes along the CoCs, annual numbers of newly- acquired HIV infections and time intervals spent between stages need to be reduced. Furthermore, strengthening of testing programs and stronger treatment and adherence support, along with HIV prevention measures, are needed to achieve HIV epidemic control and, ultimately, AIDS elimination by 2030.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinika za infektivne bolesti "Dr Fran Mihaljević"
Profili:
Josip Begovac
(autor)